Brief: Cancer Genetics Reports Q3 2020 Financial Results

Vyant Bio

12/11/2020 21:54

Nov 12 (Reuters) - Cancer Genetics Inc  CGIX.O :
    * CANCER GENETICS REPORTS THIRD QUARTER 2020 FINANCIAL
RESULTS
    * Q3 LOSS PER SHARE $0.58 FROM CONTINUING OPERATIONS
    * Q3 REVENUE FELL 24 PERCENT TO $1.6 MILLION

Source text for Eikon:  ID:nGNX6GdhM3 
Further company coverage:  CGIX.O 

 ((Reuters.Briefs@thomsonreuters.com;))